Werkgroep Cardiologische centra Nederland English

COMPASS (Follow up)

A randomized controlled trial of rivaroxaban for the prevention of cardiovascular events in patients with coronary or peripheral artery disease
Middel
rivaroxaban
Populatie
ASCVD
Fase
III
Jaar aanvang
2013
Meer informatie
ClinicalTrials.gov